Kolon Life Science Inc. (KOSDAQ:102940)

Kolon Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,414	12,498	7,561	6,371	27,800	15,001
Short-Term Investments	-	-	-	-	110	30
Cash & Short-Term Investments	7,414	12,498	7,561	6,371	27,910	15,031
Cash Growth	-11.60%	65.29%	18.68%	-77.17%	85.69%	-28.13%
Accounts Receivable	34,846	36,699	24,605	29,440	19,649	22,199
Other Receivables	568.15	1,094	1,008	302.04	638.16	398.12
Receivables	35,414	37,794	25,613	29,742	20,287	22,597
Inventory	51,585	46,726	67,777	68,494	45,998	42,790
Prepaid Expenses	4,130	4,127	3,406	4,579	3,743	7,237
Other Current Assets	664.08	909.02	688.31	998.16	82.57	12,908
Total Current Assets	99,207	102,055	105,045	110,184	98,021	100,563
Property, Plant & Equipment	121,189	115,076	123,138	125,960	131,481	141,893
Long-Term Investments	376,157	197,223	77,054	75,240	2,549	3,262
Goodwill	-	-	-	1,217	1,217	1,217
Other Intangible Assets	521.79	554.34	168.28	58.95	99.11	199.79
Long-Term Accounts Receivable	0	-0	0	-0	-0	-0
Long-Term Deferred Charges	15.01	44.86	164.25	283.64	403.04	522.43
Other Long-Term Assets	4,872	4,610	3,866	1,174	888.54	680.57
Total Assets	601,962	419,563	309,436	314,118	234,658	248,338
Accounts Payable	13,149	11,950	7,442	17,049	13,774	11,808
Accrued Expenses	3,455	4,908	4,355	3,594	3,145	2,721
Short-Term Debt	110,587	105,890	97,262	69,461	59,064	61,751
Current Portion of Long-Term Debt	9,997	9,993	-	4,000	5,333	5,333
Current Portion of Leases	877.87	692.76	428.66	287.62	336.45	348.65
Current Income Taxes Payable	-	-	-	376.36	-	-
Current Unearned Revenue	3,201	3,201	3,201	3,201	3,500	3,500
Other Current Liabilities	56,097	69,620	15,653	11,608	10,316	59,689
Total Current Liabilities	197,364	206,255	128,341	109,578	95,469	145,152
Long-Term Debt	9,069	8,699	9,980	-	4,000	9,333
Long-Term Leases	1,258	1,324	191.33	167.18	191.02	262.15
Long-Term Deferred Tax Liabilities	70,945	33,629	9,874	9,760	-	-
Other Long-Term Liabilities	13,400	13,487	16,938	17,078	25,139	25,903
Total Liabilities	300,562	270,225	171,764	146,395	135,248	190,381
Common Stock	6,212	6,212	5,706	5,706	5,706	5,706
Additional Paid-In Capital	192,801	192,801	167,553	209,114	209,542	167,980
Retained Earnings	-217,647	-228,091	-133,289	-101,537	-106,024	-104,359
Treasury Stock	-	-	-	-	-812.88	-812.88
Comprehensive Income & Other	320,035	178,417	97,702	54,440	-9,001	-10,557
Total Common Equity	301,401	149,338	137,672	167,723	99,410	57,957
Shareholders' Equity	301,401	149,338	137,672	167,723	99,410	57,957
Total Liabilities & Equity	601,962	419,563	309,436	314,118	234,658	248,338
Total Debt	131,789	126,598	107,863	73,916	68,925	77,029
Net Cash (Debt)	-124,375	-114,100	-100,301	-67,545	-41,015	-61,998
Net Cash Per Share	-10198.85	-9553.71	-8788.83	-5344.94	-3597.74	-5438.33
Filing Date Shares Outstanding	12.42	12.42	11.41	11.41	11.4	11.4
Total Common Shares Outstanding	12.42	12.42	11.41	11.41	11.4	11.4
Working Capital	-98,156	-104,200	-23,296	606.75	2,552	-44,589
Book Value Per Share	24260.75	12020.68	12063.41	14696.64	8720.06	5083.88
Tangible Book Value	300,879	148,783	137,504	166,448	98,094	56,541
Tangible Book Value Per Share	24218.75	11976.05	12048.67	14584.86	8604.64	4959.63
Land	16,281	16,281	16,281	17,286	17,008	17,024
Buildings	60,243	81,462	88,069	88,567	88,891	88,874
Machinery	25,073	108,063	104,638	101,589	102,952	90,469
Construction In Progress	17,395	13,857	17,810	16,474	15,952	28,846

Source: S&P Global Market Intelligence. Standard template. Financial Sources.